...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Diabetes/metabolism research and reviews >Considerations on blood glucose management in Type 2 diabetes mellitus.
【24h】

Considerations on blood glucose management in Type 2 diabetes mellitus.

机译：关于2型糖尿病患者血糖管理的考虑。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In recent years the benefits of more intensive management in preventing or delaying the development and progression of diabetic complications have been well documented. What is not as well documented is how to motivate the person with diabetes to manage the condition, how to set, assess and quantify glucose goals, and the glucose variables that should be routinely measured. This review discusses the importance of setting targets and communicating them in a way that the patient understands. When aiming for a glycaemia target, balance is required (1) between achieving reduction of complications and causing an increased degree of hypoglycaemia, and (2) between what is achievable and what degree of benefit is gained. Target values given in guidelines should be adapted by the clinician to take into account the patient's susceptibility to hypoglycaemia, stage and type of complications, age and life expectancy, co-morbidity, social environment, understanding of the steps required and level of commitment to the treatment. Several suggestions are given regarding possible improvements and amendments to existing guidelines for diabetes management in treating to glucose goal. For example, attention should be drawn to the need to individualise goals and to consider education, long-term support, patient needs and treatment outcome when formulating diabetes management plans. The relative properties of the different glucose variables-fasting plasma glucose (FPG), postprandial plasma glucose (PPG), glycated haemoglobin A(1c) (HbA(1c)), and glycated protein-in terms of their convenience of measurement, usefulness and relevance to the physician and patient are also evaluated. When prioritising the variables to be measured it is suggested that where feasible, HbA(1c) should be the standard measurement by which to gauge risk and treatment efficacy. Serial measurements should be made and, where possible, the use of blood glucose meters encouraged, in order to obtain a blood glucose profile for the patient.
机译：近年来，在预防或延迟糖尿病并发症的发生和发展方面加强管理的好处已得到充分证明。尚未充分记录的是如何激励糖尿病患者管理疾病，如何设定，评估和量化血糖目标以及应常规测量的血糖变量。这篇综述讨论了设定目标并以患者理解的方式传达目标的重要性。当以血糖为目标时，需要在（1）减少并发症和引起低血糖程度增加之间，以及（2）在可达到的程度和获得的益处程度之间保持平衡。临床医生应调整指南中给出的目标值，以考虑患者对低血糖的易感性，并发症的分期和类型，年龄和预期寿命，合并症，社会环境，对所需步骤的理解以及对治疗的承诺水平治疗。给出了一些建议，以改善和治疗糖尿病目标中现有的糖尿病治疗指南。例如，在制定糖尿病管理计划时，应注意个性化目标的需要，并考虑教育，长期支持，患者需求和治疗结果。从测量方便性，实用性和易用性方面考虑，不同的葡萄糖变量的相对特性-空腹血浆葡萄糖（FPG），餐后血浆葡萄糖（PPG），糖化血红蛋白A（1c）（HbA（1c））和糖化蛋白还评估了与医生和患者的相关性。建议在对要测量的变量进行优先排序时，建议在可行的情况下，将HbA（1c）作为衡量风险和治疗效果的标准方法。应该进行串行测量，并在可能的情况下，鼓励使用血糖仪，以获得患者的血糖曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号